Surmodics | SRDX - 流动负债

金融业

USD

USD 178.56M

现金及等价物

USD 36.12M

USD 33.03M

USD 81.3M

USD 20.54M

USD 29.55M

股息收益率

0

USD -322K

USD 1.53M

376

EPS每股收益

USD -0.25

股本和储备

USD 118.9M

USD -11.54M

债务利息支出

USD 884K

USD 29.55M

USD 393.5M

USD -11.54M

USD -245.35M

USD -5.65M

普通股股本

USD 716K

386.18

USD -7.51M

USD 29.92M

销售和管理费用

USD 14.58M

USD 15.17M

贸易债权人

USD 2.79M

应收帐款人

USD 23.27M

	流动负债	更改		日
Abbott	USD 16.5B		1.91B	2025-12
Align Technology	USD 1.92B		46.45M	2025-12
Anika Therapeutics	USD 21.91M		2.82M	2025-12
Arrowhead Research	USD 347.42M		151.94M	2025-12
Artivion	USD 101.56M		15.72M	2025-12
Baxter International	USD 2.97B		805M	2025-12
Boston Scientific	USD 5.44B		111M	2025-12
EDAP TMS	EUR 31.4M		2.71M	2025-09
Edwards Lifesciences	USD 1.59B		183.3M	2025-09
Haemonetics	USD 539.87M		8.45M	2025-12
Heron Therapeutics	USD 96.1M		6.39M	2025-12
J&J	USD 54.13B		3.26B	2025-12
Merit Medical Systems	USD 239.76M		9.29M	2025-12
Mesa Laboratories	USD 54.4M		6.1M	2025-12
Nektar Therapeutics	USD 66.34M		5.05M	2025-09
Option Care Health	USD 829.35M		5.44M	2025-12
Stryker	USD 7.79B		380M	2025-12
Surmodics	USD 20.54M		347K	2024-09
Trinity Biotech	USD 34.49M		2.97M	2025-09